following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv). .
one downside to existing drugs that prevent migraine is they can cause unpleasant side effects like
. (image: rex/shutterstock)
.
. when bruschi suffered a stroke in 2005, he was treated at massachusetts general hospital, which he said was well equipped to handle the medical emergency.
. yet these drugs are not a "home run," says elizabeth loder, md, a professor of neurology at harvard medical school and chief of the division of headache at brigham & women's hospital.
OFF DEAL